Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000159386 | SCV000209332 | uncertain significance | not provided | 2014-06-16 | criteria provided, single submitter | clinical testing | The Q263E variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The Q263E variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Q263E variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. Nevertheless, in silico analysis predicts this variant likely does not alter the protein structure/function. Missense mutations in nearby residues have not been reported in association with disease, suggesting this region of the protein may be tolerant of change. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in HCM panel(s). |
Center for Human Genetics, |
RCV000768534 | SCV000886853 | uncertain significance | Hypertrophic cardiomyopathy | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000768534 | SCV002199425 | uncertain significance | Hypertrophic cardiomyopathy | 2021-12-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 181674). This missense change has been observed in individual(s) with clinical features of TPM1-related conditions (PMID: 26688388, 31513939; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 263 of the TPM1 protein (p.Gln263Glu). |